On ECHEMI
Home > Drugs > Beijing Xiehe Pharmaceutical Co., Ltd.
Beijing Xiehe Pharmaceutical Co., Ltd.
  • Founded in:

    1981-04-04
  • Country:

    China China
  • Address:

    Building 7, No. 37 Yongwang Road, Daxing Biomedicine Industry Base, Zhongguancun Science Park, Daxing District, Beijing
  • Tax NO.:

    91110115101618619W
  • Registered Funds:

    60 million yuan
  • Website:

  • Email:

Related Drugs
Bicyclol Tablets
The main ingredient of this product is bicyclol.
Name Description Content CAS NO. Registered Holders
Methyl 5'-(hydroxymethyl)-7,7'-dimethoxy-[4,4'-bibenzo[d][1,3]dioxole]-5-carboxylate

It can reduce the increase of aminotransferase in acute liver damage in mice caused by carbon tetrachloride, D-galactosamine and paracetamol; it can reduce the increase of aminotransferase in immune hepatitis in mice; it can alleviate the pathological morphological damage of liver tissue to varying degrees; it can inhibit the secretion of HBeAg, HBVDNA and HBsAg in the 2.2.15 cell line of liver cancer cells transfected with human hepatitis B virus.

More

It can reduce the increase of aminotransferase in acute liver damage in mice caused by carbon tetrachloride, D-galactosamine and paracetamol; it can reduce the increase of aminotransferase in immune hepatitis in mice; it can alleviate the pathological morphological damage of liver tissue to varying degrees; it can inhibit the secretion of HBeAg, HBVDNA and HBsAg in the 2.2.15 cell line of liver cancer cells transfected with human hepatitis B virus.

118159-48-1 5
Bicyclol Tablets
The main ingredient of this product is bicyclol.
Name Description Content CAS NO. Registered Holders
Methyl 5'-(hydroxymethyl)-7,7'-dimethoxy-[4,4'-bibenzo[d][1,3]dioxole]-5-carboxylate

It can reduce the increase of aminotransferase in acute liver damage in mice caused by carbon tetrachloride, D-galactosamine and paracetamol; it can reduce the increase of aminotransferase in immune hepatitis in mice; it can alleviate the pathological morphological damage of liver tissue to varying degrees; it can inhibit the secretion of HBeAg, HBVDNA and HBsAg in the 2.2.15 cell line of liver cancer cells transfected with human hepatitis B virus.

More

It can reduce the increase of aminotransferase in acute liver damage in mice caused by carbon tetrachloride, D-galactosamine and paracetamol; it can reduce the increase of aminotransferase in immune hepatitis in mice; it can alleviate the pathological morphological damage of liver tissue to varying degrees; it can inhibit the secretion of HBeAg, HBVDNA and HBsAg in the 2.2.15 cell line of liver cancer cells transfected with human hepatitis B virus.

118159-48-1 5
Bicyclol Tablets
The main ingredient of this product is bicyclol.
Name Description Content CAS NO. Registered Holders
Methyl 5'-(hydroxymethyl)-7,7'-dimethoxy-[4,4'-bibenzo[d][1,3]dioxole]-5-carboxylate

It can reduce the increase of aminotransferase in acute liver injury in mice caused by carbon tetrachloride, D-galactosamine and paracetamol, reduce the increase of aminotransferase in immune hepatitis in mice, and alleviate the pathological morphological damage of liver tissue to varying degrees; it can inhibit the secretion of HBeAg, HBVDNA and HBsAg in the 2.2.15 cell line of liver cancer cells transfected with human hepatitis B virus.

More

It can reduce the increase of aminotransferase in acute liver injury in mice caused by carbon tetrachloride, D-galactosamine and paracetamol, reduce the increase of aminotransferase in immune hepatitis in mice, and alleviate the pathological morphological damage of liver tissue to varying degrees; it can inhibit the secretion of HBeAg, HBVDNA and HBsAg in the 2.2.15 cell line of liver cancer cells transfected with human hepatitis B virus.

118159-48-1 5
Bicyclol Tablets
The main ingredient of this product is bicyclol.
Name Description Content CAS NO. Registered Holders
Methyl 5'-(hydroxymethyl)-7,7'-dimethoxy-[4,4'-bibenzo[d][1,3]dioxole]-5-carboxylate

It can reduce the increase of aminotransferase in acute liver damage in mice caused by carbon tetrachloride, D-galactosamine and paracetamol; it can reduce the increase of aminotransferase in immune hepatitis in mice; it can alleviate the pathological morphological damage of liver tissue to varying degrees; it can inhibit the secretion of HBeAg, HBVDNA and HBsAg in the 2.2.15 cell line of liver cancer cells transfected with human hepatitis B virus.

More

It can reduce the increase of aminotransferase in acute liver damage in mice caused by carbon tetrachloride, D-galactosamine and paracetamol; it can reduce the increase of aminotransferase in immune hepatitis in mice; it can alleviate the pathological morphological damage of liver tissue to varying degrees; it can inhibit the secretion of HBeAg, HBVDNA and HBsAg in the 2.2.15 cell line of liver cancer cells transfected with human hepatitis B virus.

118159-48-1 5
Bicyclol Tablets
The main ingredient of this product is bicyclol.
Name Description Content CAS NO. Registered Holders
Methyl 5'-(hydroxymethyl)-7,7'-dimethoxy-[4,4'-bibenzo[d][1,3]dioxole]-5-carboxylate

It can reduce the increase of aminotransferase in acute liver damage in mice caused by carbon tetrachloride, D-galactosamine and paracetamol; it can reduce the increase of aminotransferase in immune hepatitis in mice; it can alleviate the pathological morphological damage of liver tissue to varying degrees; it can inhibit the secretion of HBeAg, HBVDNA and HBsAg in the 2.2.15 cell line of liver cancer cells transfected with human hepatitis B virus.

More

It can reduce the increase of aminotransferase in acute liver damage in mice caused by carbon tetrachloride, D-galactosamine and paracetamol; it can reduce the increase of aminotransferase in immune hepatitis in mice; it can alleviate the pathological morphological damage of liver tissue to varying degrees; it can inhibit the secretion of HBeAg, HBVDNA and HBsAg in the 2.2.15 cell line of liver cancer cells transfected with human hepatitis B virus.

118159-48-1 5
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.